Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

34results about How to "Enhance cell viability" patented technology

In-vitro culture method of T cells

The invention provides an in-vitro culture method of T cells, and belongs to the technical field of genetic engineering.The culture method comprises the steps that immune cell serum-free culture media are added into peripheral blood mononuclear cells, and activated culture is conducted in the presence of cell factors to obtain activated T cells; the cell factor comprises an IL-2 monoclonal antibody and a CD3 monoclonal antibody, and further comprises two or three of an iCAM1 protein, a CCL21 protein and OK432. The T cells obtained through activation and multiplication culture are relatively stable in cell phenotype, relatively large in amplification multiple, relatively high in cell viability and relatively high in tumor killing efficiency. T cells are obtained after activation is performed for 24 hours and then multiplication culture is performed for 14 days, and the number of the cells is 6.2-8.9 * 10 < 9 >; the killing rate on Hela cells is 51.9 to 74.1 percent, and the killing rate on LOVO cells is 55.7 to 80.5 percent.
Owner:SHANDONG RES INST OF ADULT CELL IND TECH CO LTD

Ketoreductase mutant as well as gene, recombinant plasmid, engineering bacterium and application of ketoreductase mutant in preparation of ethyl hydroxide

The invention belongs to the field of bioengineering, and discloses a ketoreductase mutant as well as a gene, a recombinant plasmid, an engineering bacterium and application of the ketoreductase mutant in preparation of ethyl hydroxide. The ketoreductase mutant disclosed by the invention is obtained by performing site-directed saturation mutation on amino acid key sites combined with a substrate and then performing screening, and the ketoreductase mutant is high in thallus activity, so that the dosage concentration of the substrate is increased to 10%, the conversion time is less than or equal to 24 hours, and the ee value is greater than or equal to 99.0%; therefore, the production of the ketone reduction product ethyl hydroxide of the ethyl condensate is more efficient and environment-friendly. According to the method, the ethyl hydroxide is prepared by adopting the gene for coding the ketoreductase or the ketoreductase mutant, the operation is simple, the production efficiency is high, the conversion rate is high, the yield is high, and basically no other impurities are generated.
Owner:HUNAN NORCHEM PHARMACEUTICAL CO LTD

Application of hypericin nanoparticles subjected to photodynamic treatment in preparation of drugs for inhibiting liver cancer cells

The invention provides application of hypericin nanoparticles subjected to photodynamic treatment in preparation of a medicine for inhibiting liver cancer cells. The hypericin nanoparticles (HC-NPs) are formed by wrapping a traditional Chinese medicine monomer hypericin (HC) with distearoyl phosphatidyl ethanolamine-polyethylene glycol 2000 (DSPE-PEG2000). The hypericin nano-particles provided by the invention have an obvious inhibition effect on liver cancer cells under a specific illumination condition, so that the expression of the gene SERPINE1 is up-regulated in a time-dependent and dose-dependent manner. The gene participates in regulation of biological behaviors of liver cancer, and provides a new view angle for treatment of liver cancer.
Owner:AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIV

Culture medium, its use and microtumor culture method

PendingCN122648352Aenhance cell viabilitygood experimental foundationBiotechnologyArginine
The application belongs to the field of biological medicine, and discloses a culture medium, which comprises a basic culture medium, and the basic culture medium is added with ITS-A: 1x, arginine: 15-20 mu g / ml, SPP1: 3-5 mu g / ml and S100A9: 3-5 mu g / ml. The culture medium is particularly suitable for microtumor culture of MTC model and has good cell viability. Meanwhile, the application also provides application of the culture medium and a microtumor culture method.
Owner:HUANZHOU (GUANGDONG HENGQIN) BIOTECHNOLOGY CO LTD

Polypeptide with repairing effect and application thereof

The invention relates to the technical field of polypeptides, and mainly relates to a polypeptide with a repairing effect and application thereof. The polypeptide contains the following amino acid sequence: (EVDEQMLNVQNK) n, wherein n is any one natural number from 3 to 10. The polypeptide can significantly improve the activity and proliferation of keratinocytes, and has an excellent effect of promoting skin repair.
Owner:XIAN HUIPU BIOTECH CO LTD

Photopolymerization rapid prototyping transparent medical hydrogel patch and preparation method thereof

The invention relates to the technical field of hydrogel application, in particular to a photopolymerization rapid prototyping transparent medical hydrogel application and a preparation method thereof. The invention discloses a transparent medical hydrogel patch capable of being rapidly formed through photopolymerization. The transparent medical hydrogel patch comprises hydrogel, the hydrogel is prepared by the following steps: coating a release film with a pre-polymerization liquid containing ultraviolet light activity, and carrying out polymerization molding through ultraviolet light irradiation. According to the transparent medical hydrogel patch, vinyl monomers serve as raw materials, the hydrogel patch is prepared in a coating mode, the problem that leveling is difficult when the hydrogel patch is injected into a mold is solved, continuous batch production can be carried out, the hydrogel patch can be completely formed only by 5-15 s of UV polymerization time, and the light polymerization efficiency is remarkably improved.
Owner:WINNER MEDICAL CO LTD +1

Method for modifying cell

Provided is a method for modifying a cell, which comprises the following steps: transfecting a target molecule and a screening marker molecule to a cell in a non-viral manner, so that the cell expresses the target molecule and the screening marker molecule. Also provided is a modified cell obtained using the method. The method can effectively enrich the desired cell and increase cell positivity with respect to the target molecule.
Owner:CELLS & GENES BIOTECH (SHANGHAI) CO LTD

Natural molecule with whitening and light damage resisting functions in white mulberry root-bark and preparation method of natural molecule

ActiveCN119264202Aenhance cell viabilityInhibits tyrosinase activityOrganic active ingredientsCosmetic preparationsBiotechnologyMulberry Root Bark
The invention relates to a natural molecule with whitening and light damage resistance in white mulberry root-bark and a preparation method of the natural molecule. The natural molecule specifically is aesculetin-7-O-primurin. The natural molecule is obtained by taking white mulberry root-bark as a raw material, performing ethanol extraction, performing first separation on the white mulberry root-bark extract by utilizing an ethanol-water system, performing second separation by utilizing a methanol-water system and performing third separation by utilizing the methanol-water system. The aesculetin-7-O-primuroside disclosed by the invention has a relatively good application prospect in development of cosmetics with whitening and light damage resisting effects or dual effects.
Owner:KUNMING INST OF BOTANY CHINESE ACAD OF SCI +1

Application of hemp seed composition in preparation of medicine for treating hashimoto thyroiditis

The invention provides application of a semen cannabis composition in preparation of a medicine for treating hashimoto thyroiditis, and belongs to the technical field of traditional Chinese medicine, and the semen cannabis composition comprises the following raw material components in parts by mass: 20-25 parts of semen cannabis, 10-15 parts of Chinese herbaceous peony, 10-15 parts of immature bitter orange, 25-30 parts of rheum officinale, 1-5 parts of mangnolia officinalis and 10-15 parts of almond. The hemp seed kernel composition can relieve TgAb-induced thyroid follicular cell proliferation inhibition, apoptosis, cell migration, inflammatory factor overexpression and other injuries and can adjust the T4 secretion level, and the research finds that a new thought is provided for later treatment of HT.
Owner:HENAN UNIV OF CHINESE MEDICINE

Cryopreservation of NK cell products for spot immunotherapy

Provided herein are methods for inactivating effector cells (e.g., NK cells, including cells as spot type cells for adoptive cell therapy). The inactivated cells can be cryopreserved after inactivation. The inactivated cells may be expanded and / or activated prior to inactivation, and may or may not include a transgene, which may optionally encode a chimeric antigen receptor and / or a T cell receptor. In certain embodiments, disclosed are methods for inactivating NK cells comprising treating with an inactivating agent, which is a kinase inhibitor, such as an mTOR inhibitor, and / or a tyrosine kinase inhibitor, such as rapamycin and / or dasatinib. Also provided herein are inactivated and cryopreserved NK cells, and methods of making and / or using the same for treating a subject in need thereof (e.g., treating a subject having cancer).
Owner:BOARD OF RGT THE UNIV OF TEXAS SYST

Culture medium and method for culturing digestive tract tumors by using three-dimensional tumor chip technology

The invention discloses a culture medium and a method for culturing digestive tract tumors by using a three-dimensional tumor chip technology. The culture medium is prepared from the following components: 5-10% v / v of FBS, 20-30% v / v of a Ham's F12 nutrient solution, 0.10-0.15 ng / mL of a recombinant human epidermal growth factor (EGF), 20-30 ng / mL of hydrocortisone, 0.05-0.15 nM of cholera toxin, 4-6 g / mL of insulin, 9-11 M of Y-27632 dihydrochloride, 10-30 [mu] g / mL of cefoperazone sodium, 5-15 [mu] g / mL of sulbactam sodium and the balance of DMEM (Dulbecco Modified Eagle Medium). The culture medium not only reduces the pollution rate, but also is high in cell activity and has an immune microenvironment similar to that of an original tissue, so that it is possible that an in-vitro 3D-TSCs culture method evaluates the drug sensitivity of immunotherapy drugs for clinical digestive tract tumors, and the culture medium has very high clinical application value and market potential.
Owner:ZHUHAI UM SCI & TECH RES INST +1

Application of RARRES1 in diagnosis and treatment of retinal injury diseases

The invention provides an application of RARRES1 in diagnosis and treatment of retinal injury diseases. It is found for the first time that the RARRES1 is significantly down-regulated in the neovascular age-related macular degeneration, and overexpression of the RARRES1 can significantly inhibit apoptosis of ARPE-19 cells under H2O2 conditions and improve the cell viability of ARPE-19, provides a new direction for diagnosis and effective treatment of the neovascular age-related macular degeneration, and has a wide application prospect.
Owner:THE SECOND HOSPITAL OF HEBEI MEDICAL UNIV

Anti-cancer composition containing phellinus igniarius extract and total ginsenoside and application of anti-cancer composition

PendingCN121943980AStrong inhibitory activitySynergy is clearFungi medical ingredientsRespiratory disorderPhellinus linteus extractAqueous ethanol
The invention relates to the technical field of medical health care products, in particular to an anticancer composition containing phellinus igniarius extract and total ginsenoside and application of the anticancer composition. The anticancer composition comprises a phellinus igniarius extract and total saponins of ginseng. The mass ratio of the phellinus igniarius extract to the total ginsenoside is 1: (0.5-2); the phellinus igniarius extract is obtained by taking artificially cultivated phellinus igniarius as a raw material through ultrasonic-assisted extraction and reflux extraction in stages; the extraction solvent is selected from water or an ethanol water solution with the ethanol concentration not exceeding 40%. The anticancer composition provided by the invention has remarkable in-vitro anticancer activity and low toxicity to normal cells.
Owner:CHANGCHUN UNIV OF SCI & TECH

A serum-free culture medium for γδT cells and its application

ActiveCN118703437Benhance cell viabilityIncrease multipleCulture processBlood/immune system cellsT cellCell kill
The present invention belongs to the field of biotechnology, and in particular to a serum-free medium for γδT cells and its application, wherein the medium includes a basal medium and an added complex, wherein the basal medium is any one of an X-Vivo15 medium or a KBM581 medium; the added complex includes: TWS119 with a final concentration of 0.5-5 μM / L, MnTBAP chloride with a final concentration of 1-10 μM / L, DL-α-tocopherol acetate with a final concentration of 0.5-2 mg / L, and zoledronic acid with a final concentration of 1-20 μM / L. The culture medium of the present invention cultivates γδT cells without the need for additional addition of serum or serum substitutes, can significantly improve the γδT cell expansion multiple, and can improve the transduction efficiency of CAR into γδT cells, while having good CAR-γδT cell killing tumor cell efficiency.
Owner:GENETIMES EXCELL TECH INC

A method for culturing T cells in vitro

ActiveCN119286780BIncrease multipleenhance cell viabilityBlood/immune system cellsCell culture active agents
The present invention provides an in vitro culture method of T cells, which belongs to the field of genetic engineering technology. The culture method is to add immune cell serum-free culture medium to peripheral blood mononuclear cells, and perform activation culture in the presence of cytokines to obtain activated T cells; the cytokines include IL-2, CD3 monoclonal antibodies, and two or three of iCAM1 protein, CCL21 protein, and OK432. The T cells obtained by the activation and amplification culture of the present invention have a relatively stable cell phenotype, a large amplification multiple, a high cell viability, and a high tumor killing efficiency. The T cells obtained by the present invention after activation for 24 hours and then amplification culture for 14 days have a cell number of 6.2-8.9×10 9 cells; the killing rates for Hela cells were 51.9-74.1%, and for LOVO cells were 55.7-80.5%.
Owner:SHANDONG RES INST OF ADULT CELL IND TECH CO LTD

Kits, methods, and single-cell library preparation techniques for the dissociation of marine animal tissues

PendingCN122303377AMeet the needs of database constructionenhance cell viabilitySingle cell suspensionTissue sample
This invention provides a kit, method, and single-cell library construction method for the dissociation of marine animal tissues. The dissociation method includes: S1) dissociating marine animal tissue samples at 8℃~12℃ using a cell dissociation buffer to obtain a single-cell suspension; S2) centrifuging the single-cell suspension and washing the single-cell precipitate obtained after centrifugation with a cell resuspension buffer to obtain single cells from the marine animal tissue sample; wherein, the cell dissociation buffer comprises a protease; the protease is Bacillus subtilis protease A; the concentration of sodium ions in the cell resuspension buffer is 300-800mM, and the concentration of potassium ions is 5-20mM.
Owner:BGI RESEARCH SANYA

Cryoprotectant compositions containing DNA nanostructures and methods of use thereof

ActiveCN115867134Benhance cell viabilityPeptidesDead animal preservation
The present invention relates to a composition for cryoprotection, the composition comprising: a nucleic acid structure comprising a scaffold nucleic acid that folds at a predetermined position and forms a plurality of chains, and a plurality of staple nucleic acids that form a double strand by binding to at least one of the chains and at least a portion of which has a complementary sequence to the scaffold nucleic acid; a linker bound to at least a portion of the nucleic acid structure; and a peptide bound to at least a portion of the linker, wherein the composition can increase cell viability during cryopreservation of cells and tissues and allows the texture of the food to be maintained when used for frozen food.
Owner:KOREA UNIV RES & BUSINESS FOUND +1

A method for amplifying tumor-infiltrating T lymphocytes derived from autologous cancerous pleural effusion and ascites

The present invention discloses a method for amplifying tumor-infiltrating T lymphocytes derived from autologous cancerous pleural effusion, which belongs to the field of cell separation and culture technology, and includes the following steps: S1, collection of autologous pleural effusion; S2, preparation of samples to be sorted; S3, addition of sorting magnetic beads; S4, elution and loading; S5, elution of non-target cells and elution and collection of target cells; S6, in vitro activation of tumor-infiltrating T lymphocytes; S7, in vitro amplification of tumor-infiltrating T lymphocytes; S8, identification and harvesting of tumor-infiltrating T lymphocytes. The amplification method provided by the present invention can fully activate TIL cells by using nano-scale particles coupled to CD3 / CD28 antibodies to activate tumor-infiltrating T lymphocytes obtained by sorting and purification, so that the proliferation ability of TIL cells is greatly improved, and sufficient TIL cells can be obtained at the end of culture.
Owner:西安国际医学中心有限公司

Perfusion medium for mammalian CHO (Chinese hamster ovary) cells and application of perfusion medium

The invention provides a perfusion culture medium for mammalian CHO cells and application of the perfusion culture medium, and belongs to the technical field of cell culture. The perfusion medium provided by the invention contains a metal compound, saccharides, vitamins, amino acids, nucleoside / nucleoside compounds, fatty acids and other components. The perfusion culture medium provided by the invention can support culture of cells of different subtypes, is beneficial to production and subculture of CHO cells, enables the cells to maintain a relatively good motility rate in a fermentation period, and is beneficial to efficient expression of protein products; the produced substances are high in purity and less in charge variants, so that the development of biological pharmacy downstream plates is facilitated, and the production cost of protein products is saved; the culture medium is simple to prepare and beneficial to commercialized large-scale production.
Owner:SHERPA BIOTECHNOLOGY (HANGZHOU) CO LTD

Benzothiazine 1,1-dioxide compounds that inhibit HDAC6 enzyme, their preparation methods and applications

This invention provides a benzothiadiazine 1,1-dioxide compound, its preparation method, and its applications. The general structural formula of the benzothiadiazine 1,1-dioxide compound is shown in Formula (I), or its isomers, or pharmaceutically acceptable salts, esters, or prodrugs thereof. The benzothiadiazine 1,1-dioxide compound of this invention has a novel structure, can selectively inhibit HDAC6 enzyme, has a strong protective effect on nerve cells, low toxicity, and low potential cardiotoxicity, and is expected to be used as a neuroprotective agent for the treatment of neurodegenerative diseases.
Owner:SHANGHAI INST OF PHARMA IND CO LTD

Activity detection method of stress-induced mesenchymal stem cell extract

The invention belongs to the field of medicines, and discloses an activity detection method of a stress-induced mesenchymal stem cell extract, which comprises the following steps: pre-culturing BV2 cells, preparing more than three groups of mesenchymal stem cell extract culture mediums with different concentrations, and detecting the anti-inflammatory performance of the mesenchymal stem cell extract. Wherein the model group and the drug delivery group are established, lipopolysaccharide induced inflammation stimulation is performed on BV2 cells in the model group and the drug delivery group, then the BV2 cells are respectively transferred to a corresponding blank culture medium and a culture medium containing a mesenchymal stem cell extract for incubation, and finally BV2 cell culture supernate is taken for Elisa detection to obtain the concentration of inflammatory factors. According to the detection method disclosed by the embodiment of the invention, a safe experimental concentration and a data result with good repeatability and significance can be screened out, a performance monitoring model of the mesenchymal stem cell extract can be established, the product quality can be stabilized, the change rule of the product concentration and the anti-inflammatory activity can be explored, and a basis is established for subsequently using the mesenchymal stem cell extract as an inflammation inhibitor.
Owner:DARWIN BIOTECHNOLOGY (HUBEI) CO LTD

A lipid complex for mammalian cell culture medium and its preparation method and application

The present invention discloses a lipid complex for mammalian cell culture medium and its preparation method and application, belonging to the field of cell culture technology. The lipid complex includes lipid substances, organic solvents, solubilizers and water prepared in a certain proportion; the lipid substances include one or more of α-linolenic acid, γ-linolenic acid, oleic acid, linoleic acid, eicosapentaenoic acid, docosahexaenoic acid, myristic acid, lauric acid, arachidonic acid and palmitic acid. The lipid complex of the present invention not only has clear chemical composition and is safe and harmless, but also has a simplified formula and excellent performance. It can effectively increase cell growth density and cell viability and increase the yield of target protein when added to the culture medium, and has broad application value.
Owner:SHANGHAI MAIBANG BIOTECHNOLOGY CO LTD

Thymus tissue dissociation reagent, kit and application thereof in obtaining thymus epithelial cells

PendingCN122256250ADissociation is effectiveenhance cell viabilityBlood/immune system cellsDNA - Deoxyribonucleic acidDispase
The application belongs to the technical field of biological medicine, and particularly relates to a thymus tissue dissociation reagent, a kit and application thereof in obtaining thymus epithelial cells. The thymus tissue dissociation reagent at least comprises collagenase D, dispersinase II, deoxyribonuclease I, dissociation enzyme and a dissolving reagent; and collagenase II and / or collagenase IV and / or trypsin. The cell survival rate of the thymus tissue dissociation reagent after dissociating the thymus tissue is maintained at a high level of 95.7% to 99.6%, which is significantly higher than that of the prior art; and after sorting, the number of thymus epithelial cells enriched and obtained from each gram of thymus tissue is 1.38e 5 ~1.06e 6 , and the success rate of enriching and obtaining thymus epithelial cells is as high as 95%, which is significantly higher than that of the prior art; and the proportion of epithelial stem cells in the thymus epithelial cells is 65.7%, which is significantly higher than that of the prior art.
Owner:CHONGQING INT INST OF IMMUNOLOGY

Preparation method and application of respiratory tract sample single-cell suspension

The invention relates to a preparation method and application of a respiratory tract sample single-cell suspension. The method comprises the following steps: putting a fresh respiratory tract sample into a sterile collection bottle; adding a Dulbecco improved Eagle culture medium until the volume is 5-30ml, then adding a liquefying agent for liquefying, and liquefying in a water bath at the temperature of 30-40 DEG C for 10-30 minutes; centrifuging, and absorbing and discarding the supernatant; adding a mild cell digestive enzyme to resuspend the cells, and incubating to obtain a cell suspension; filtering is performed; centrifuging, and absorbing and discarding the supernatant; dMEM and 9-11% of fetal calf serum are added to resuspend the cells, and a single-cell suspension is obtained.
Owner:INST OF PATHOGEN BIOLOGY CHINESE ACADEMY OF MEDICAL SCI

Application of marine-derived alkaloid in preparation of anti-cholestasis medicine

PendingCN121943914ARelieve stasis liver diseaseenhance cell viabilityOrganic active ingredientsDigestive systemBile JuiceDiketopiperazines
The invention discloses an application of marine-derived alkaloid in preparation of an anti-cholestasis medicine, and belongs to the field of natural medicines. The invention discloses an application of indolediketopiperazine alkaloid 12R, 13S-Dihydroxyfumitorgin C (DHFC) or a pharmaceutically acceptable salt of the indolediketopiperazine alkaloid in preparation of an agonist of a peroxisome proliferator-activated receptor delta (PPAR delta), and an application of the indolediketopiperazine alkaloid 12R, 13S-Dihydroxyfumitorgin C (DHFC) or the pharmaceutically acceptable salt of the indolediketopiperazine alkaloid in preparation of an anti-cholestasis medicine, and the indolediketopiperazine alkaloid 12R, 13S-Dihydroxyfumitorgin C (DHFC) or the pharmaceutically acceptable salt of the indolediketopiperazine alkaloid has a protective effect on cholestasis by activating the PPAR delta. DHFC is in high-affinity binding with an LBD region of PPAR delta, the transcriptional level of downstream genes of PPAR delta is increased, the affinity KD of DHFC to PPAR delta protein is 153nM, and the DHFC plays a synergistic treatment role in multiple links of improving bile acid homeostasis, inhibiting inflammation, relieving liver fibrosis and the like. The invention provides a new lead compound for the development of anti-cholestasis drugs, and has important significance for the development of Chinese marine-derived drugs. Formula (I)
Owner:SOUTHERN MEDICAL UNIVERSITY

Pyrannose derivatives, processes for their preparation and uses thereof

PendingCN122541491Aenhance cell viabilityInhibit cellular inflammatory factor levels
The application discloses a kind of pyranose derivatives represented by the following general formula I, its stereoisomer, pharmaceutically acceptable salt, crystalline hydrate or solvate, its preparation method, the pharmaceutical composition for protecting the compounds and its application in central nervous system diseases and inflammatory diseases etc..According to the pyranose derivative of the application, the cell viability of A beta 1-42 induced cell damage model is significantly improved, the cell viability of 6-hydroxydopamine induced cell damage model is improved, the cell viability of oxygen-glucose deprivation / reoxygenation cell damage model is improved, the level of lipopolysaccharide induced cell inflammatory factor is inhibited, etc.The pharmacological effects have good clinical application prospect.
Owner:VIGONVITA SHANGHAI CO LTD +2

Use of the protein ambp in the preparation of a formulation for promoting hair follicle cell activity or for the prevention or treatment of hair loss

ActiveCN121695257Bpromote proliferationHas the ability to scavenge reactive oxygen speciesPeptide/protein ingredientsDermatological disorderCell activityBiochemistry
The present application belongs to the field of biomedical and cosmetic technology, and particularly relates to the application of protein AMBP in the preparation of a preparation for promoting the activity of hair follicle cells or for preventing and treating alopecia. The present application first discovers that the protein AMBP has the activity of regulating the hair follicle hair papilla cells, hair matrix cells and outer root sheath cells, can promote the proliferation of the hair papilla cells, the hair matrix cells and the outer root sheath cells, and improve the ability of the outer root sheath cells to remove active oxygen; also has the effects of promoting the hair follicle cycle transition, promoting hair growth and hair thickening. Therefore, the protein AMBP can be applied to the preparation of a preparation for treating alopecia.
Owner:SOUTHERN MEDICAL UNIVERSITY

Method for separating and culturing hematopoietic stem cells from umbilical cord blood

The invention provides a method for separating and culturing umbilical cord blood-derived hematopoietic stem cells, which comprises the step of preparing hematopoietic stem cells by using a hydroxyethyl starch (HES) precipitation method, and the used hydroxyethyl starch solution contains sodium selenite and phosphoryl dipeptide. The recovery rate of the hematopoietic stem cells obtained by the method is increased, and the removal rate of red blood cells is also increased.
Owner:SHANGHAI YUANSHENGKE PHARMACEUTICAL TECHNOLOGY CO LTD